|
GS185131: GO:0044699 single-organism process
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS136433: pulmonary adenoma susceptibility 5a (Pas5a, Published QTL Chr 11)
|
|
GS208901: GO:0005859 muscle myosin complex
|
|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS136647: serum IGFBP-5 level QTL 6 (Si5lq6, Published QTL Chr 11)
|
|
GS201949: GO:0044699 single-organism process
|
|
GS187749: GO:0019220 regulation of phosphate metabolic process
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS856: Sey_Pax6_Int_No_Chng_No_Chng
|
|
GS129172: pregnancy QTL 2 (Pregq2 Published QTL Chr 11)
|
|
GS136853: Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 5 (Tmevd5, Published QTL Chr 11)
|
|
GS181223: GO:0046434 organophosphate catabolic process
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS188698: GO:0003012 muscle system process
|
|
GS208912: GO:0046700 heterocycle catabolic process
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS197054: GO:0006195 purine nucleotide catabolic process
|
|
GS182747: GO:0032781 positive regulation of ATPase activity
|
|
GS136605: spinal bone mineral density 4 (Sbmd4, Published QTL Chr 11)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS135389: body growth early QTL 10 (Bgeq10, Published QTL Chr 11)
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS196934: GO:0065008 regulation of biological quality
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS136798: total body bone mineral density 5 (Tbbmd5, Published QTL Chr 11)
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS136208: liver weight QTL 9 (Lwq9, Published QTL Chr 11)
|
|
GS202188: GO:0044248 cellular catabolic process
|
|
GS205610: GO:0044430 cytoskeletal part
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS204630: GO:1901565 organonitrogen compound catabolic process
|
|
GS135818: ethanol induced thermoregulation 4 (Ethm4, Published QTL Chr 11)
|
|
GS192672: GO:0055086 nucleobase-containing small molecule metabolic process
|
|
GS135496: brain weight QTL 1 (Brwq1, Published QTL Chr 11)
|
|
GS200490: GO:0061061 muscle structure development
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS195875: GO:0030049 muscle filament sliding
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS190628: GO:0003779 actin binding
|
|
GS180276: GO:0006195 purine nucleotide catabolic process
|
|
GS191106: GO:0044464 cell part
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS201251: GO:0044424 intracellular part
|
|
GS135528: castaneus 10 week body weight 3 (C10bw3, Published QTL Chr 11)
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS136767: streptozotocin induced diabetes susceptibility (Stzid, Published QTL Chr 11)
|
|
GS207523: GO:0003779 actin binding
|
|
GS177311: GO:1901361 organic cyclic compound catabolic process
|
|
GS136696: systematic lupus erythematosus susceptibility 13 (Sle13, Published QTL Chr 11)
|
|
GS187839: GO:0060048 cardiac muscle contraction
|
|
GS136481: plasmacytoma susceptibility 3 (Pcyts3, Published QTL Chr 11)
|
|
GS188701: GO:0003015 heart process
|
|
GS136780: seizure susceptibility 3 (Szs3, Published QTL Chr 11)
|
|
GS178803: GO:0051336 regulation of hydrolase activity
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS203608: GO:0034655 nucleobase-containing compound catabolic process
|
|
GS181721: GO:0006163 purine nucleotide metabolic process
|
|
GS177565: GO:0009166 nucleotide catabolic process
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS183388: GO:1900542 regulation of purine nucleotide metabolic process
|
|
GS184456: GO:0009894 regulation of catabolic process
|
|
GS208978: GO:0043169 cation binding
|
|
GS203266: GO:0006140 regulation of nucleotide metabolic process
|
|
GS189748: GO:0050790 regulation of catalytic activity
|
|
GS135973: wound healing/regeneration 10 (Heal10, Published QTL Chr 11)
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS87378: Table S2: The data provided represent genes showing differential expression using ANOVA. (Whole Table) [DRG]
provisional
|
|
GS199545: GO:0032781 positive regulation of ATPase activity
|
|
GS198624: GO:0033275 actin-myosin filament sliding
|
|
GS135815: ethanol induced ataxia 10 (Etax10, Published QTL Chr 11)
|
|
GS189106: GO:0008015 blood circulation
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS210139: GO:0016460 myosin II complex
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS189443: GO:0044449 contractile fiber part
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS178401: GO:0019637 organophosphate metabolic process
|
|
GS186744: GO:0043226 organelle
|
|
GS206312: GO:0044449 contractile fiber part
|
|
GS182835: GO:0005622 intracellular
|
|
GS136952: weight gain in high growth mice 7 (Wg7, Published QTL Chr 11)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS135812: estradiol regulated response QTL 3 (Estq3, Published QTL Chr 11)
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS194613: GO:0008092 cytoskeletal protein binding
|
|
GS208021: GO:0051345 positive regulation of hydrolase activity
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS210177: GO:0031329 regulation of cellular catabolic process
|
|
GS177870: GO:0008092 cytoskeletal protein binding
|
|
GS880: Alcohol acceptance preference and sensitivity mice
|
|
GS135792: epilepsy 6 (El6, Published QTL Chr 11)
|
|
GS84255: alcohol preference locus (Published QTL, Chr 11)
|
|
GS204054: GO:0044057 regulation of system process
|
|
GS206742: GO:0043167 ion binding
|
|
GS206781: GO:0009116 nucleoside metabolic process
|
|
GS135906: gonadal fat pad weight QTL 1 (Gfpq1, Published QTL Chr 11)
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS205560: GO:0003015 heart process
|
|
GS182524: GO:0002026 regulation of the force of heart contraction
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS136119: body length 6 (Lgth6, Published QTL Chr 11)
|
|
GS136357: novelty/stress induced locomotor activation 8 (Nsila8, Published QTL Chr 11)
|
|
GS182699: GO:0051174 regulation of phosphorus metabolic process
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS188699: GO:0003013 circulatory system process
|
|
GS136528: prion disease incubation time 3 (Prdt3, Published QTL Chr 11)
|
|
GS194302: GO:0009166 nucleotide catabolic process
|
|
GS189432: GO:0043462 regulation of ATPase activity
|
|
GS181473: GO:0005488 binding
|
|
GS136388: autoimmune orchitis resistance 3 (Orch3, Published QTL Chr 11)
|
|
GS136957: weight 5 (Wght5, Published QTL Chr 11)
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS186328: GO:0033121 regulation of purine nucleotide catabolic process
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS189896: GO:0009117 nucleotide metabolic process
|
|
GS180155: GO:0065009 regulation of molecular function
|
|
GS129115: collagen induced arthritis 40 (Cia40 Published QTL Chr 11)
|
|
GS181666: GO:0019439 aromatic compound catabolic process
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS204610: GO:0019220 regulation of phosphate metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS136789: tail length QTL 8 (Tailq8, Published QTL Chr 11)
|
|
GS135461: bone mineral density 7 (Bomd7, Published QTL Chr 11)
|
|
GS193991: GO:0048731 system development
|
|
GS199495: GO:0051174 regulation of phosphorus metabolic process
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS136244: methamphetamine response QTL 3 (Marq3, Published QTL Chr 11)
|
|
GS136831: TNF-induced lethal shock susceptibility 2 (Tilss2, Published QTL Chr 11)
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS199651: GO:0005198 structural molecule activity
|
|
GS198263: GO:0005488 binding
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS200955: GO:0008307 structural constituent of muscle
|
|
GS135755: experimental allergic encephalomyelitis susceptibility 22 (Eae22, Published QTL Chr 11)
|
|
GS183168: GO:0031672 A band
|
|
GS195151: GO:0019637 organophosphate metabolic process
|
|
GS191982: GO:0030016 myofibril
|
|
GS125802: Asbestos, Serpentine interacting genes (MeSH:D017632) in CTD
|
|
GS188962: GO:1901292 nucleoside phosphate catabolic process
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS179139: GO:0008016 regulation of heart contraction
|
|
GS193018: GO:0003008 system process
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS135341: atherosclerosis 19 (Ath19, Published QTL Chr 11)
|
|
GS180084: GO:0003785 actin monomer binding
|
|
GS203173: GO:0033121 regulation of purine nucleotide catabolic process
|
|
GS202895: GO:0030811 regulation of nucleotide catabolic process
|
|
GS187833: GO:0060047 heart contraction
|
|
GS184447: GO:0044424 intracellular part
|
|
GS189897: GO:0009116 nucleoside metabolic process
|
|
GS205557: GO:0003012 muscle system process
|
|
GS207862: GO:0009056 catabolic process
|
|
GS198455: GO:0019439 aromatic compound catabolic process
|
|
GS136477: periosteal circumference 2 (Pcir2, Published QTL Chr 11)
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS135274: "alcohol preference locus 18, male specific" (Alcp18, Published QTL Chr 11)
|
|
GS191983: GO:0030017 sarcomere
|
|
GS193489: GO:0072521 purine-containing compound metabolic process
|
|
GS210435: GO:0072521 purine-containing compound metabolic process
|
|
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS210437: GO:0072523 purine-containing compound catabolic process
|
|
GS203335: GO:0048513 organ development
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS180164: GO:0008150 biological_process
|
|
GS206301: GO:0043462 regulation of ATPase activity
|
|
GS198012: GO:0046434 organophosphate catabolic process
|
|
GS205972: GO:0008015 blood circulation
|
|
GS191700: GO:0006753 nucleoside phosphate metabolic process
|
|
GS210709: GO:0070252 actin-mediated cell contraction
|
|
GS199968: GO:0031672 A band
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS205558: GO:0003013 circulatory system process
|
|
GS186108: GO:0006936 muscle contraction
|
|
GS123911: Ozone interacting genes (MeSH:D010126) in CTD
|
|
GS187769: GO:1901564 organonitrogen compound metabolic process
|
|
GS206780: GO:0009117 nucleotide metabolic process
|
|
GS198369: GO:0017022 myosin binding
|
|
GS208012: GO:0044464 cell part
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS210212: GO:0005575 cellular_component
|
|
GS135766: experimental allergic encephalomyelitis susceptibility 7 (Eae7, Published QTL Chr 11)
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS190954: GO:0009056 catabolic process
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS181167: GO:0006941 striated muscle contraction
|
|
GS124594: 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid interacting genes (MeSH:C472791) in CTD
|
|
GS87119: Table S2: The data provided represent genes showing differential expression using ANOVA. B. Genes showing main effect of treatment. [DRG]
provisional
|
|
GS205825: GO:1901292 nucleoside phosphate catabolic process
|
|
GS204692: GO:0060047 heart contraction
|
|
GS205123: GO:0030029 actin filament-based process
|
|
GS204698: GO:0060048 cardiac muscle contraction
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS136543: periosteal circumference 2 (Pstc2, Published QTL Chr 11)
|
|
GS189317: GO:0043292 contractile fiber
|
|
GS186421: GO:0006140 regulation of nucleotide metabolic process
|
|
GS195905: GO:0008016 regulation of heart contraction
|
|
GS136677: skull morphology 16 (Skull16, Published QTL Chr 11)
|
|
GS182834: GO:0005623 cell
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS136434: pulmonary adenoma susceptibility 5b (Pas5b, Published QTL Chr 11)
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS201260: GO:0009894 regulation of catabolic process
|
|
GS207365: GO:0005829 cytosol
|
|
GS186758: GO:0034655 nucleobase-containing compound catabolic process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS136328: non-insulin-dependent diabetes mellitus 4 (Nidd4, Published QTL Chr 11)
|
|
GS193233: GO:0031329 regulation of cellular catabolic process
|
|
GS207161: GO:0006928 cellular component movement
|
|
GS122142: Dietary Fats interacting genes (MeSH:D004041) in CTD
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|
|
GS208922: GO:0030017 sarcomere
|
|
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
|
|
GS195876: GO:0030048 actin filament-based movement
|
|
GS201256: GO:0044422 organelle part
|
|
GS136337: nicotine induced locomotor activity 2 (Nilac2, Published QTL Chr 11)
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS201431: GO:0005515 protein binding
|
|
GS136708: semilethal sex-restricted (Slthsr, Published QTL Chr 11)
|
|
GS197098: GO:0032036 myosin heavy chain binding
|
|
GS196933: GO:0065009 regulation of molecular function
|
|
GS136514: protein kinase C content in lungs (Pkccl, Published QTL Chr 11)
|
|
GS136560: QTL for body weight independent of sex 3 (Qbis3, Published QTL Chr 11)
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS136086: kidney weight QTL 15 (Kwq15, Published QTL Chr 11)
|
|
GS205224: GO:0015629 actin cytoskeleton
|
|
GS199267: GO:0043234 protein complex
|
|
GS206520: GO:0051015 actin filament binding
|
|
GS191115: GO:0051345 positive regulation of hydrolase activity
|
|
GS206620: GO:0050790 regulation of catalytic activity
|
|
GS198511: GO:0006163 purine nucleotide metabolic process
|
|
GS125062: palm oil interacting genes (MeSH:C041786) in CTD
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS184065: GO:0043085 positive regulation of catalytic activity
|
|
GS135507: body weight QTL 4 (Bw4, Published QTL Chr 11)
|
|
GS197076: GO:0005509 calcium ion binding
|
|
GS202941: GO:0006936 muscle contraction
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS184629: GO:0005515 protein binding
|
|
GS136566: retinoic acid induced forelimb autopod reduction (Rafar, Published QTL Chr 11)
|
|
GS208636: GO:0006753 nucleoside phosphate metabolic process
|
|
GS187770: GO:1901565 organonitrogen compound catabolic process
|
|
GS195559: GO:0051336 regulation of hydrolase activity
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS135386: berghei resistance locus 2 (Berr2, Published QTL Chr 11)
|
|
GS180152: GO:0065007 biological regulation
|
|
GS197028: GO:0016459 myosin complex
|
|
GS86984: Table S2: The data provided represent genes showing differential expression using ANOVA. A. Genes showing main effect of strain. [DRG]
provisional
|
|
GS185366: GO:0044248 cellular catabolic process
|
|
GS194775: GO:0007517 muscle organ development
|
|
GS194041: GO:1901361 organic cyclic compound catabolic process
|
|
GS199319: GO:0002026 regulation of the force of heart contraction
|
|
GS206785: GO:0009118 regulation of nucleoside metabolic process
|
|
GS135366: B.burgdorferi-associated arthritis 4 (Bbaa4, Published QTL Chr 11)
|
|
GS186063: GO:0030811 regulation of nucleotide catabolic process
|
|
GS201002: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS135353: Alzheimer's disease modifier 5 (Azdm5, Published QTL Chr 11)
|
|
GS196806: GO:0032502 developmental process
|
|
GS129196: Tmc1 modifier 2 (Tmc1m2 Published QTL Chr 11)
|
|
GS84253: alcohol preference locus (Published QTL, Chr 11)
|
|
GS186633: GO:0044093 positive regulation of molecular function
|
|
GS203594: GO:0043226 organelle
|
|
GS196858: GO:0003785 actin monomer binding
|
|
GS135276: "alcohol preference locus 20, female specific" (Alcp20, Published QTL Chr 11)
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS189901: GO:0009118 regulation of nucleoside metabolic process
|
|
GS193491: GO:0072523 purine-containing compound catabolic process
|
|
GS209960: GO:0003008 system process
|
|
GS184198: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS136632: small effect CIA locus 6 (Secia6, Published QTL Chr 11)
|
|
GS191973: GO:0046700 heterocycle catabolic process
|
|
GS200182: GO:1900542 regulation of purine nucleotide metabolic process
|
|
GS135555: CD8 memory T cell subset 4 (Cd8mts4, Published QTL Chr 11)
|
|
GS194505: GO:1901135 carbohydrate derivative metabolic process
|
|
GS197099: GO:0032038 myosin II heavy chain binding
|
|
GS206183: GO:0043292 contractile fiber
|
|
GS136439: peak bone density 1 (Pbd1, Published QTL Chr 11)
|
|
GS209614: GO:0055086 nucleobase-containing small molecule metabolic process
|
|
GS136220: mandible length 12 (Manln12, Published QTL Chr 11)
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS135295: acute lung injury QTL 1 (Aliq1, Published QTL Chr 11)
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS135678: compensatory renal hypertrophy QTL 1 (Crhq1, Published QTL Chr 11)
|
|
GS180166: GO:0008152 metabolic process
|
|
GS197956: GO:0006941 striated muscle contraction
|
|
GS36154: Neocortex Gene expression correlates of Locomotor response of 10 mg/kg MDMA injected on Day 2 in Females & Males BXD
|
|
GS83981: cocaine related behavior 12 (Cocrb12, Published QTL, Chr 11)
|
|
GS204066: GO:0045159 myosin II binding
|
|
GS84254: nicotine sensitivity (Published QTL,Chr 11)
|
|
GS136517: platelet count 2 (Pltct2, Published QTL Chr 11)
|
|
GS187193: GO:0044057 regulation of system process
|
|
GS136896: visual placing (Vispl, Published QTL Chr 11)
|
|
GS36158: Neocortex Gene expression correlates of Locomotor response of 10 mg/kg MDMA injected on Day 2 in Females BXD
|
|
GS189647: GO:0051015 actin filament binding
|
|
GS177766: GO:1901135 carbohydrate derivative metabolic process
|
|
GS87379: Table S2: The data provided represent genes showing differential expression using ANOVA. (Whole Table) [DRG]
provisional
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS208921: GO:0030016 myofibril
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|